SPONSOR
Assiut University
Total Trials
3
Recruiting
3
Phases
Phase 3
Assiut University is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Respiratory Distress Syndrome, GERD, Sepsis.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Assiut University
How many clinical trials has Assiut University sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Assiut University, of which 3 are actively recruiting participants. These trials cover conditions including Respiratory Distress Syndrome, GERD, Sepsis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Assiut University research focus on?
Assiut University clinical trials span Respiratory Distress Syndrome, GERD, Sepsis. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Assiut University clinical trial?
To participate in a Assiut University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Assiut University trials with current recruitment status updated daily.
Clinical Trials by Assiut University
NCT06874478
Recruiting
Respiratory Distress and Elective Cesarean Section at Term
Respiratory Distress Syndrome
NCT06457334
Recruiting
Effect of Helicobacter Pylori Eradication on Gastroesophageal RefIux Disease (GERD)
GERD
NCT04910464 Phase 3
Recruiting
Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis
Sepsis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology